{"id":"W4281755690","doi":"10.1200/jco.2022.40.16_suppl.tps3167","title":"Design and rationale of a phase 1 dose-escalation study of AMG 193, a methylthioadenosine (MTA)-cooperative PRMT5 inhibitor, in patients with advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Amgen","keywords":"Medicine; Protein arginine methyltransferase 5; Cancer research; CDKN2A; Cancer; Tolerability; Pharmacology; Methyltransferase; Internal medicine; Adverse effect; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006266695,0.002522673,0.003015713,0.0008752542,0.001057651,0.001817005,0.001994244,0.002617797,0.01046009],"category_scores_gemma":[0.003741604,0.001693777,0.001639405,0.0008220745,0.001530444,0.001533105,0.0008199216,0.00686447,0.00371193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001791717,"about_ca_system_score_gemma":0.004826773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006449281,"about_ca_topic_score_gemma":0.002283202,"domain_scores_codex":[0.9980731,0.0008959335,0.00008981256,0.0004282356,0.0002123441,0.0003004733],"domain_scores_gemma":[0.9984688,0.0002229909,0.0002234603,0.0001921631,0.0001801546,0.0007123349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6351684,0.1228997,0.007676834,0.004576549,0.001923032,0.000877315,0.0007967897,0.008288193,0.05884496,0.005209716,0.01531831,0.1384202],"study_design_scores_gemma":[0.507277,0.4295207,0.004686991,0.0003215999,0.001050942,0.0004399543,0.0001614486,0.002168111,0.005997718,0.002728776,0.04554372,0.0001030635],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.4057018,0.0102148,0.01353241,0.004575991,0.002306247,0.5362079,0.009120575,0.0005472976,0.01779302],"genre_scores_gemma":[0.4996109,0.006552452,0.03229903,0.008496231,0.0007425674,0.4369837,0.004895537,0.0001621215,0.01025755],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01046009,"threshold_uncertainty_score":0.03499258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03601285776840743,"score_gpt":0.3841774413935174,"score_spread":0.34816458362511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}